We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

Oral Paxlovid (nirmatrelvir-ritonavir) is highly effective at preventing hospitalization and death from COVID-19, yet it has been remarkably underused, even by patients at highest risk from COVID-19, ...

Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...

Despite frequent mentions of scientific evidence, U.S. media largely ignored uncertainties and relied on non-experts, fueling public confusion during the early COVID-19 crisis. In a recent study ...

Testing positive for COVID-19 is not exactly a positive experience. After all, wanting to go viral these days doesn’t tend to mean wanting to be infected by the severe acute respiratory syndrome ...

There’s no evidence showing that remdesivir, the first treatment approved for COVID-19, killed patients taking the drug. The antiviral drug is still approved by the U.S. Food and Drug Administration ...

Jaan Kumar Sanu has tested positive for COVID-19, raising concerns about a possible rise in cases. An internal medicine ...

As monsoon-related illnesses surge every year, consumers should not assume that every expense will automatically be reimbursed ...